Innatoss Laboratories

Executive Summary

Innatoss Laboratories is a specialized diagnostic laboratory based in Oss, Netherlands, dedicated to advanced immunological testing for complex infectious diseases such as Lyme disease, Q fever, and COVID-19. Founded in 2014, the company combines diagnostic services with research to enable early detection and prevent long-term health impairment. As a small, independent entity, Innatoss operates in the niche of specialized diagnostics, differentiating itself through its focus on complex infections that often require sophisticated testing beyond standard panels. With no disclosed funding or valuation, the company appears to be bootstrapped or privately funded, relying on revenue from its diagnostic services. The global market for Lyme disease diagnostics is growing due to increasing incidence, and the post-pandemic environment continues to sustain demand for COVID-19 testing. However, Innatoss faces challenges from larger competitors and the need for continuous innovation to maintain relevance. The company's success hinges on its ability to validate its tests clinically, secure reimbursement, and expand its test menu.

Upcoming Catalysts (preview)

• Q1 2027Launch of a multiplex assay for tick-borne diseases60% success
• Q3 2026Partnership with a major hospital group for Q fever testing50% success
• Q4 2026CE-IVD certification for a new COVID-19 variant test70% success